ClinicalTrials.gov
ClinicalTrials.gov Menu

Muscle Strength and Functional Autonomy of Elderly Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01553396
Recruitment Status : Completed
First Posted : March 14, 2012
Last Update Posted : March 14, 2012
Sponsor:
Information provided by (Responsible Party):
Euro-American Network of Human Kinetics

Brief Summary:
This study shows an evaluation of the correlation between the muscle strength levels and functional autonomy of elderly women.

Condition or disease
Muscle, Ligament and Fascia Disorders

Detailed Description:
The aim of this study was to evaluate the correlation between the muscle strength levels and functional autonomy of elderly women with impaired muscle-skeletal system depending on the normal IGF-1 level. The target-population was composed by elderly women aged between 60 and 75 years (age: 67.79 ± 5.11 years, BMI: 28.01 ± 5.4), residents of an asylum, with IGF-1 levels within the normal values for the age (normo-IGF-1). Evaluations of the muscle strength (1-RM test) and the functional autonomy (GDLAM Protocol) in the performance of activities of daily living (ADL), and a measurement of basal serum levels of IGF-1 (Chemiluminescence method) were performed.

Study Type : Observational
Actual Enrollment : 35 participants
Observational Model: Case-Only
Official Title: Muscle Strength and Functional Autonomy of Normo-IGF-1 Elderly Women With Skeletal Muscle Dysfunctions
Study Start Date : January 2009
Actual Primary Completion Date : February 2009
Actual Study Completion Date : April 2009



Biospecimen Retention:   Samples Without DNA
Whole blood


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   60 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The population consists of 123 elderly women residents of São Lucas shelter, located in Cacimba Velha, Teresina-PI, Brazil. The sample consists of 35 elderly women. The elderly participants in the study signed a written informed consent.
Criteria

Inclusion Criteria:

  • present a muscle-skeletal dysfunction, such as osteoporosis, arthritis, tendinitis, but being able to perform their ADL without help from others;
  • did not practice physical activity for at least 12 months;
  • provide a normal IGF-1 level for their age;

Exclusion Criteria:

  • elderly women unfit to perform the strength and functional autonomy tests for the medical assessment;

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01553396


Sponsors and Collaborators
Euro-American Network of Human Kinetics
Investigators
Study Chair: Estélio HM Dantas, DSc University Castelo Branco (Rio de Janeiro, Brazil)

Responsible Party: Euro-American Network of Human Kinetics
ClinicalTrials.gov Identifier: NCT01553396     History of Changes
Other Study ID Numbers: 0165/2008
First Posted: March 14, 2012    Key Record Dates
Last Update Posted: March 14, 2012
Last Verified: March 2012

Additional relevant MeSH terms:
Muscular Diseases
Musculoskeletal Diseases
Neuromuscular Diseases
Nervous System Diseases